Cognex is the IBD Stock Of The Day as the machine vision specialist is seen as a winner in the industrial automation trend.
Ambarella stock soared on Tuesday after the fabless AI chipmaker received a bullish report from a Wall Street analyst.
AbbVie’s $10.9B Apogee deal strengthens immunology beyond Humira, adds Zumilokibart optionality, and may be undervalued. See ...
A systematic review found that creatine may help ease depressive symptoms when added to standard treatment, but trial results ...
Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a Biologics License Application (BLA) filing ...
Treatment for many gastrointestinal cancers is becoming increasingly personalized, thanks to advances in genetic research, targeted therapies and a deeper understanding of how individual tumors behave ...
Spyre Therapeutics is building a long-acting antibody platform across IBD and rheumatology. Read why I only rate SYRE stock a ...
Allegro MicroSystems, Inc. (NASDAQ:ALGM) is one of the High Growth Semiconductor Stocks to Buy Now. Allegro MicroSystems, Inc ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...